Cabergoline: all 51 studies that test it
Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Combination Osilodrostat and Cabergoline in Cushing's DiseaseEnrolling by invitationNCT07603466Phase 4
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNCT07568574Not applicable
- Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast SymptomsRecruitingNCT07492160Phase 2
- Safety and Potency of a High Cabergoline Dosage in MicroprolactinomasRecruitingNCT07463235Phase 3
- Carbergoline for Antipsychotic Induced Hyperprolactinemia.Not yet recruitingNCT07386080Phase 4
- Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOSRecruitingNCT07255911Not applicable
- A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate TabletsRecruitingNCT07124221Phase 3
- Cabergoline for Episodic MigraineRecruitingNCT07072910Phase 2
- Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist TreatmentRecruitingNCT07045935Phase 4
- Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation SyndromeRecruitingNCT07043322Phase 2
- Cabergoline in the Management of Nonfunctioning Pituitary AdenomaEnrolling by invitationNCT07034859Phase 4
- Pharmacological Inhibition of Lactation After 16 to 20 Week AbortionCompletedNCT06123026Phase 4Results posted
- Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy LossCompletedNCT06029673Phase 2Results posted
- Cabergoline for Lactation Inhibition After Second-Trimester Abortion or LossCompletedNCT04701333Phase 2Results posted
- Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot StudyCompletedNCT02542410Phase 2Results posted
- Cabergoline in Metastatic Breast CancerCompletedNCT01730729Early Phase 1Results posted
- Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant ProlactinomasCompletedNCT01620138Phase 2/3Results posted
- A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy LossWithdrawnNCT06909123Phase 2
- Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOSCompletedNCT05981742Phase 2
- Cabergoline as a Preventive Treatment for Chronic MigraineCompletedNCT05525611Not applicable
- Lactation Inhibition, the Efficiency of Vitamin B6 Versus CabergolineCompletedNCT05024422Not applicable
- Satisfaction of Patients With the Chosen Method of Inhibition of LactationStatus unknownNCT04038749Not applicable
- Cabergoline for the Treatment of Chronic Pain Due to EndometriosisCompletedNCT03928288Phase 2
- Cabergoline As An Adjuvant To Clomiphene Citrate For Management Of Unexplained InfertilityStatus unknownNCT03549741Phase 2/3
- Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome PreventionCompletedNCT03473613Phase 3
- Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With ProlactinomaStatus unknownNCT03457389Not applicable
- Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM PatientsStatus unknownNCT03313661Phase 3
- Cabergoline in Nonfunctioning Pituitary AdenomasCompletedNCT03271918Phase 3
- Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-ProtocolStatus unknownNCT03263299Phase 4
- Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary SyndromeStatus unknownNCT02644304Phase 2
- Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm InjectionStatus unknownNCT02306564Phase 2/3
- Dopamine Agonist Treatment of Non-functioning Pituitary AdenomasActive, not recruitingNCT02288962Phase 3
- Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation SyndromeCompletedNCT02271360Phase 2/3
- Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation SyndromeCompletedNCT02134249Phase 2/3
- A Pilot Study of Cabergoline for the Treatment of Cocaine DependenceCompletedNCT01651364Phase 1
- Ovarian Hyperstimulation Syndrome and CabergolineCompletedNCT01569256Not applicable
- Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS BiomarkersCompletedNCT01535859Phase 3
- Cabergoline Effect on Blood Sugar in Type 2 DiabeticsStatus unknownNCT01459601Not applicable
- Effect of Cabergoline on Weight and Glucose ToleranceCompletedNCT01395602Phase 1/2
- Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.Status unknownNCT01143584Not applicable
- Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) ProgramCompletedNCT01009567Phase 1/2
- Study of Cabergoline in Treatment of Corticotroph Pituitary TumorCompletedNCT00889525Phase 3
- Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting ConditionsCompletedNCT00653055Phase 1
- Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed ConditionsCompletedNCT00652873Phase 1
- A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLSCompletedNCT00627003Phase 3
- A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLSCompletedNCT00625547Phase 3
- Cabergoline Reduces OHSSCompletedNCT00440258Phase 3
- Efficacy of Octreotide Acetate and Cabergoline in Patients With AcromegalyCompletedNCT00376064Phase 4
- Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's DiseaseCompletedNCT00153972Phase 4
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's DiseaseCompletedNCT00129181Not applicable
- A Study of Cabergoline for the Treatment of Cocaine Dependence - 1CompletedNCT00033111Phase 2